Patents by Inventor Mummini Aruna Murty

Mummini Aruna Murty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained-Release Oral Dosage Forms for Low Aqueous Solubility Compounds
    Publication number: 20190125678
    Abstract: Oral dosage forms that contain hydrogel-forming polymers useful for achieving sustained release of API. The formulations disclosed herein may include a hydrogel-forming polymer and a water-insoluble hydrophilic polymer, which acts as a wicking agent to draw water into the formulation. Through that wicking, water combines with the hydrogel-forming polymer to form a hydrogel, thus permitting efficient and sustained release of the API from the hydrogel-forming polymer which may act as a matrix for the API. The formulations disclosed herein are particularly useful for sustained-release of a relatively water-insoluble API, such as tamsulosin, budesonide, and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: January 29, 2016
    Publication date: May 2, 2019
    Applicant: MYLAN, INC.
    Inventors: Mummini Aruna Murty, John N. Twist, Boyong Li
  • Controlled release levetiracetam formulations and methods for producing the same
    Patent number: 9333175
    Abstract: Pharmaceutical compositions in the form of tablets are disclosed including water-soluble active ingredients such as levetiracetam and a polymer component which primarily includes water-insoluble polymers comprising between 60% and 100% of the polymer component in the tablet core, preferably the entire polymer component in the tablet core. The pharmaceutical compositions can also include an extended-release coating including both water-soluble and water-insoluble polymers.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: May 10, 2016
    Assignee: Mylan Inc.
    Inventors: Mummini Aruna Murty, Boyong Li
  • Controlled release budesonide minitablets
    Patent number: 8945616
    Abstract: Embodiments of a controlled release minitablet comprise an extended release core and an optional pH dependent delayed release coating thereon, wherein the extended release core comprises budesonide, a carrier, and an extended release polymer. The budesonide may be embedded in the extended release polymer to facilitate extended release of the budesonide upon administration.
    Type: Grant
    Filed: February 17, 2009
    Date of Patent: February 3, 2015
    Assignee: Mylan Pharmaceuticals Inc.
    Inventors: Mummini Aruna Murty, Boyong Li
  • Controlled release budesonide minitablets
    Patent number: 8945615
    Abstract: Embodiments of a controlled release minitablet comprise an extended release core and an optional pH dependent delayed release coating thereon, wherein the extended release core comprises budesonide, a carrier, an extended release polymer, and an acid. The budesonide may be embedded in the extended release polymer to facilitate extended release of the budesonide upon administration.
    Type: Grant
    Filed: February 17, 2009
    Date of Patent: February 3, 2015
    Assignee: Mylan Pharmaceuticals Inc.
    Inventors: Mummini Aruna Murty, Boyong Li
  • CONTROLLED RELEASE LEVETIRACETAM FORMULATIONS AND METHODS FOR PRODUCING THE SAME
    Publication number: 20110311627
    Abstract: Pharmaceutical compositions in the form of tablets are disclosed including water-soluble active ingredients such as levetiracetam and a polymer component which primarily includes water-insoluble polymers comprising between 60% and 100% of the polymer component in the tablet core, preferably the entire polymer component in the tablet core. The pharmaceutical compositions can also include an extended-release coating including both water-soluble and water-insoluble polymers.
    Type: Application
    Filed: June 16, 2010
    Publication date: December 22, 2011
    Inventors: Mummini Aruna Murty, Boyong Li
  • CONTROLLED RELEASE BUDESONIDE MINITABLETS
    Publication number: 20100209501
    Abstract: Embodiments of a controlled release minitablet comprise an extended release core and an optional pH dependent delayed release coating thereon, wherein the extended release core comprises budesonide, a carrier, and an extended release polymer. The budesonide may be embedded in the extended release polymer to facilitate extended release of the budesonide upon administration.
    Type: Application
    Filed: February 17, 2009
    Publication date: August 19, 2010
    Inventors: Mummini Aruna Murty, Boyong Li
  • CONTROLLED RELEASE BUDESONIDE MINITABLETS
    Publication number: 20100209500
    Abstract: Embodiments of a controlled release minitablet comprise an extended release core and an optional pH dependent delayed release coating thereon, wherein the extended release core comprises budesonide, a carrier, an extended release polymer, and an acid. The budesonide may be embedded in the extended release polymer to facilitate extended release of the budesonide upon administration.
    Type: Application
    Filed: February 17, 2009
    Publication date: August 19, 2010
    Inventors: Mummini Aruna Murty, Boyong Li